Acerus Pharmaceuticals (FRA:3TP0) Change In Receivables : €0.90 Mil (TTM As of Sep. 2022)

View and export this data going back to 2014. Start your Free Trial

What is Acerus Pharmaceuticals Change In Receivables?

Acerus Pharmaceuticals's change in receivables for the quarter that ended in Sep. 2022 was €-0.11 Mil. It means Acerus Pharmaceuticals's Accounts Receivable increased by €0.11 Mil from Jun. 2022 to Sep. 2022 .

Acerus Pharmaceuticals's change in receivables for the fiscal year that ended in Dec. 2021 was €0.92 Mil. It means Acerus Pharmaceuticals's Accounts Receivable declined by €0.92 Mil from Dec. 2020 to Dec. 2021 .

Acerus Pharmaceuticals's Accounts Receivable for the quarter that ended in Sep. 2022 was €1.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Acerus Pharmaceuticals's Days Sales Outstanding for the three months ended in Sep. 2022 was 117.76.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Acerus Pharmaceuticals's liquidation value for the three months ended in Sep. 2022 was €-55.79 Mil.

Acerus Pharmaceuticals Change In Receivables Historical Data

The historical data trend for Acerus Pharmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acerus Pharmaceuticals Change In Receivables Chart

Acerus Pharmaceuticals Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Change In Receivables

Get a 7-Day Free Trial

3.17

0.55

0.46

-0.11

0.92

Acerus Pharmaceuticals Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Change In Receivables	Get a 7-Day Free Trial															-0.75	1.57	-0.20	-0.37	-0.11

Acerus Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.90 Mil.

Acerus Pharmaceuticals (FRA:3TP0) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Acerus Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Sep. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1.004	/	0.778	*	91
=	117.76

2. In Ben Graham's calculation of liquidation value, Acerus Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

Acerus Pharmaceuticals's liquidation value for the quarter that ended in Sep. 2022 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3.05	-	62.181	+	0.75 * 1.004	+	0.5 * 5.171
=	-55.79

Acerus Pharmaceuticals Change In Receivables Related Terms

Thank you for viewing the detailed overview of Acerus Pharmaceuticals's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Acerus Pharmaceuticals (FRA:3TP0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acerus Pharmaceuticals Corp (FRA:3TP0) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

7025 Langer Drive, Suite 205, Mississauga, ON, CAN, L5N 0E8

Website

https://www.aceruspharma.com

Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.

Acerus Pharmaceuticals (FRA:3TP0) Headlines

No Headlines